The Oncology Pharmacist
  • Home
  • Issues
    • 2022
      • May 2022 - Vol 15 No 3
      • March 2022 - Vol 15 No 2
      • January 2022 - Vol 15 No 1 – Online Only
    • 2021
      • November 2021 - Vol 14 No 7
      • October 2021 - Vol 14 No 6 | Biosimilars
      • September 2021 - Vol 14 No 5
      • July 2021 - Vol 14 No 4
      • May 2021 - Vol 14 No 3
      • March 2021 - Vol 14 No 2
      • January 2021 - Vol 14 No 1
    • 2020
      • November 2020, Vol 13, No 6
      • September 2020 - Vol 13 no 5
      • July 2020 - Vol 13 no 4
      • May 2020 - Vol 13 no 3
      • March 2020 - Vol 13 no 2
      • January 2020 - Vol 13 No 1
    • 2019
      • November 2019 - Vol 12 No 4
      • August 2019 - Vol 12 No 3
      • May 2019 - Vol 12 No 2
      • February 2019 - Vol 12 No 1
    • Issue Archive
  • Special Issues
    • Supplements
      • ASK THE EXPERT: First-Line Treatment of Metastatic Non-small cell Lung Cancer
        • Part 1
    • Guide to New FDA Approvals
      • 2019 Fourth Annual Guide
      • 2018 Third Annual Guide
      • 2017 Second Annual Guide
      • 2016 First Annual Guide
  • Categories
  • Conference Correspondent
    • ASCO 2021 Wrap-Up - Breast Cancer
  • Web Exclusives
    • Ovarian Cancer Overview
    • Interview with the Innovators
    • All Web Exclusives
    • Drug Updates
    • FDA Approvals, News & Updates
    • In the News
    • Press Releases
    • Online First
    • Media Library
      • Videos
      • Audiocasts
  • Quick Quiz
  • CE
  • About
    • About TOP
    • Advertise
    • Editorial Board
    • Contact Us
    • Resources
    • Submit
      • Author Guidelines
The Oncology Pharmacist

Dalia Buffery, MA, ABD

The Lynx Group
Cranbury, NJ
Authored Items
New Indications Approved by the FDA in 2018 for Oncology Drugs
Dalia Buffery, MA, ABD
2019 Fourth Annual Oncology Guide to New FDA Approvals in FDA Updates
Last modified: June 5, 2019
Latest Issue
 
  • Privacy Policy
  • Terms of Use
  • Home
  • About
  • Subscribe
  • Advertise
  • Contact Us

© Green Hill Healthcare Communications, LLC, an affiliate of The Lynx Group. All rights reserved.
1249 South River Road - Suite 202, Cranbury, NJ 08512

  • Home
  • Issues
    • 2022
      • May 2022 - Vol 15 No 3
      • March 2022 - Vol 15 No 2
      • January 2022 - Vol 15 No 1 – Online Only
    • 2021
      • November 2021 - Vol 14 No 7
      • October 2021 - Vol 14 No 6 | Biosimilars
      • September 2021 - Vol 14 No 5
      • July 2021 - Vol 14 No 4
      • May 2021 - Vol 14 No 3
      • March 2021 - Vol 14 No 2
      • January 2021 - Vol 14 No 1
    • 2020
      • November 2020, Vol 13, No 6
      • September 2020 - Vol 13 no 5
      • July 2020 - Vol 13 no 4
      • May 2020 - Vol 13 no 3
      • March 2020 - Vol 13 no 2
      • January 2020 - Vol 13 No 1
    • 2019
      • November 2019 - Vol 12 No 4
      • August 2019 - Vol 12 No 3
      • May 2019 - Vol 12 No 2
      • February 2019 - Vol 12 No 1
    • Issue Archive
  • Special Issues
    • Supplements
      • ASK THE EXPERT: First-Line Treatment of Metastatic Non-small cell Lung Cancer
        • Part 1
    • Guide to New FDA Approvals
      • 2019 Fourth Annual Guide
      • 2018 Third Annual Guide
      • 2017 Second Annual Guide
      • 2016 First Annual Guide
  • Categories
  • Conference Correspondent
    • ASCO 2021 Wrap-Up - Breast Cancer
  • Web Exclusives
    • Ovarian Cancer Overview
    • Interview with the Innovators
    • All Web Exclusives
    • Drug Updates
    • FDA Approvals, News & Updates
    • In the News
    • Press Releases
    • Online First
    • Media Library
      • Videos
      • Audiocasts
  • Quick Quiz
  • CE
  • About
    • About TOP
    • Advertise
    • Editorial Board
    • Contact Us
    • Resources
    • Submit
      • Author Guidelines
Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".
First Name *
Last Name *
Email Address *
Email Address (Verify) *
We will request your mailing address on the next page.
We will request your mailing address on the next page.